© 2021 MJH Life Sciences and Diagnostic Imaging. All rights reserved.
© 2021 MJH Life Sciences™ and Diagnostic Imaging. All rights reserved.
June 17, 2021
Recently approved PMSA-targeted radiotracer can pinpoint biochemical recurrent prostate cancer in men with unhelpful standard imaging.
June 16, 2021
Patients with mild cognitive impairment who take lipophilic statins have a more than doubled risk of progressing to dementia.
Tested so far in animal models, this tracer could further the development of treatments for this life-threatening disease for which there are currently no therapies.
June 14, 2021
New therapy uses light from decaying radiopharmaceuticals to attack cancer cells from inside the body.
June 13, 2021
Using an external tracking device can lead to super-resolution that can potentially improve neurological disorder detection.
June 12, 2021
Use enables direct imaging of disease process.
June 11, 2021
Using advanced artificial intelligence can give patients a personalized assessment of their risk for significant events, such as heart attack or death.
July 17, 2020
Images reveal older adults with above-average cognitive abilities have a resistance to tau and amyloid proteins.
July 16, 2020
Using 18F-DCPyL PSMA PET/CT can pinpoint more cancers in men who have biochemical failure with initial treatment.
July 15, 2020
Using PET/MRI 18F NaF offers new functional measure for assessing degeneration of knee joints.